Navigation Links
Cerealus Announces Licensing Agreement for Bio-Based Ceregel™, A Next Generation Strength and Retention System
Date:4/15/2010

Sustainable Technology Trailblazer Cerealus Holdings to Commercialize UMaine Commercial Paper-Making Technology, Ceregel™

Waterville, ME (Vocus) April 15, 2010 -- Cerealus Holdings, in collaboration with the University of Maine, is excited to announce their latest bio-based technology, “Ceregel™, A Next Generation Strength + Retention System.” Originally patented by DuPont and later developed by the UMaine Process Development Center, Ceregel™ is a smart process proven technology for paper mills that will enable improved productivity and lower production costs.

Ceregel™ utilizes five patents and involves cooking cationic polyacrylamides with cationic starch to form “super” starch molecules, which have improved retention properties for commercial paper machines. Ceregel™ benefits and validated effects include increased strength, increased retention, and higher press solids. Cerealus has secured exclusive licensing rights for Ceregel™ from the University of Maine and recently initiated a full sales and installation campaign.

"This unique technology is an exciting addition to our technology portfolio, and we have already begun an aggressive commercialization campaign," says Tony Jabar, CEO of Cerealus Holdings. "Our process improvements will provide paper mills with various optimization solutions and should enable mills to save up to $14 per ton.”

Mike Bilodeau, Director of the Process Development Center at the University of Maine, went on to say, “This groundbreaking new low-capital technology gives paper makers a range of options to improve product quality, productivity, and lower manufacturing costs. We believe this technology will soon be considered “best known practice” in the industry, deployed across a wide range of paper grades and manufacturing processes.”

In addition to Ceregel™, Cerealus develops a number of sustainable technologies including Holdout™, a non-toxic, biodegradable replacement for fluorinated compounds; Agricultural Mulch Film; compost bags that are odor, water and grease resistant; biodegradable greenhouse film; construction, household, and general purpose plant-based adhesives; and a plant-based coating binder used to replace oil-based, synthetic binders. For more information, visit Cerealus Holdings or call 207-649-1147.

Cerealus Holdings, LLC
Founded in 2004 by Chemist Tony Jabar, Cerealus Holdings, LLC is headquartered in Waterville, ME. The company develops biodegradable, renewable, plant-based materials to replace synthetic compounds, using cutting-edge science and research to unearth sustainable solutions for current and emerging market opportunities. The non-toxic alternatives we provide address a number of varied markets, from food packaging to paper mills to agricultural crop protection. For more information, visit http://www.cerealus.com or call 207-649-1147.

###

Read the full story at http://www.prweb.com/releases/cerealus/ceregel/prweb3875364.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cerealus Announces Licensing Agreement for Bio-Based Ceregel™,  A Next Generation Strength and Retention System
(Date:12/2/2016)... CytRx Corporation (NASDAQ: CYTR ), ... today announced the appointment of Earl Warren Brien ... private healthcare investor, to its Board of Directors. ... and strategic experience at the highest level," said ... one of the world,s leading orthopedic surgeons, Dr. Brien ...
(Date:12/2/2016)... ... 01, 2016 , ... Aerocom Healthcare ( http://www.aerocomhealthcare.com ), representing ... its chain-of-custody solution for tracking and securing medications at booth 676 at the ... , Aerocom has a proven solution for tracking medications via its system from ...
(Date:12/2/2016)... ... December 01, 2016 , ... Orthogonal, a Chicago-based medical device ... Class II 510(k) clearance for their flagship medical device, SimplECG. , With this ... devices that rely on cloth-based nanosensors. While other companies have attempted to focus ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected to reach ... during the forecast period of 2016 to 2021 dominated by immunohistochemistry ... the largest share of immunohistochemistry (IHC) market, by end user.   ... , , ... across 225 pages, profiling 10 companies and supported with 181 tables ...
Breaking Biology Technology:
(Date:11/19/2016)... 2016 Securus Technologies, a leading provider of ... investigation, corrections and monitoring, announced today that it has ... have an independent technology judge determine who has the ... tech/sophisticated telephone calling platform, and the best customer service. ... most of what we do – which clearly is ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/27/2016)... Research and Markets has announced the addition ... to their offering. The report ... to grow at a CAGR of 12.28% during the period 2016-2020. ... in-depth market analysis with inputs from industry experts. The report covers ... The report also includes a discussion of the key vendors operating ...
Breaking Biology News(10 mins):